Anna Prats

Badalona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Interactions between gut microbiota, plasma metabolome and brain function in the setting of a HIV cure trial.

Interactions between gut microbiota, plasma metabolome and brain function in the setting of a HIV cure trial.

Journal: Frontiers in cellular and infection microbiology

Published: May 16, 2025

Short Assessment for People with Human Immunodeficiency Virus (HIV) Aged 50 Years or Older: Essential Tests from Comprehensive Geriatric Assessment.

Short Assessment for People with Human Immunodeficiency Virus (HIV) Aged 50 Years or Older: Essential Tests from Comprehensive Geriatric Assessment.

Journal: Viruses

Published: April 29, 2025

Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial.

Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial.

Journal: Nature communications

Published: July 17, 2024

Long COVID: cognitive, balance, and retina manifestations.

Long COVID: cognitive, balance, and retina manifestations.

Journal: Frontiers in medicine

Published: March 11, 2024

Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.

Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.

Journal: The Lancet regional health. Europe

Published: July 07, 2023

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.

Journal: Journal of virology

Published: January 31, 2023

Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination.

Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination.

Journal: EBioMedicine

Published: January 17, 2023

Feasibility of a wearable inertial sensor to assess motor complications and treatment in Parkinson's disease.

Feasibility of a wearable inertial sensor to assess motor complications and treatment in Parkinson's disease.

Journal: PloS one

Published: May 02, 2022

Neurocognitive Profile of the Post-COVID Condition in Adults in Catalonia-A Mixed Method Prospective Cohort and Nested Case-Control Study: Study Protocol.

Neurocognitive Profile of the Post-COVID Condition in Adults in Catalonia-A Mixed Method Prospective Cohort and Nested Case-Control Study: Study Protocol.

Journal: Vaccines

Published: April 26, 2022

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.

Journal: Scientific reports

Published: December 09, 2020

Long-Term Effects in Bone Mineral Density after Different Bariatric Procedures in Patients with Type 2 Diabetes: Outcomes of a Randomized Clinical Trial.

Long-Term Effects in Bone Mineral Density after Different Bariatric Procedures in Patients with Type 2 Diabetes: Outcomes of a Randomized Clinical Trial.

Journal: Journal of clinical medicine

Published: May 08, 2020

NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV.

NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV.

Journal: The Journal of the Association of Nurses in AIDS Care : JANAC

Published: December 27, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026